Trial NCT01017822

View at ClinicalTrials.gov 
Org. Study IDs: RTOG-0932
Secondary IDs: CDR0000659527

Last trial update was posted on 2013-06-24

MeSH Interventions

Capecitabine Conatumumab Gemcitabine

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

Pancreatic Cancer

Stopping Reasons

This study was withdrawn due to study agent availability.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID